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Abstract
Following the introduction of West Nile virus into California during the summer of 2003, public 
health and vector control programs expanded surveillance efforts and were in need of diagnostics 
capable of rapid, sensitive, and specific detection of arbovirus infections of mosquitoes to inform 
decision support for intervention. Development of a multiplex TaqMan or real-time 
semiquantitative RT-PCR assay in which three virus specific primer/probe sets were used in the 
same reaction is described herein for the detection of western equine encephalomyelitis, St. Louis 
encephalitis and West Nile viral RNA. Laboratory validation as well as field data from 10 
transmission seasons are reported. The comparative sensitivity and specificity of this multiplex 
assay to singleplex RT-PCR as well as an antigen detection (RAMP) and standard plaque assays 
indicate this assay to be rapid and useful in providing mosquito infection data to estimate outbreak 
risk.
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INTRODUCTION
Arthropod-borne virus surveillance for decision support to direct intervention by public 
health and mosquito control agencies requires the rapid and accurate detection of viruses of 
human health importance. Although fourteen mosquito-borne viruses were known to occur 
in California prior to 2003, only two caused significant human and/or equine disease and 
have been the focus of statewide surveillance and intervention efforts (Reeves et al. 1990). 
Western equine encephalomyelitis virus (WEEV, Togaviridae, Alphavirus) was isolated 
originally from an equine fatality during a large equine epizootic in the Central Valley of 
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California in the 1930s (Meyer et al. 1931), was a frequent cause of summer encephalitis in 
children (Howitt 1939), and was responsible for a large epidemic of human encephalitis in 
1952 (Reeves and Hammon 1962). St. Louis encephalitis virus (SLEV, Flaviviridae, 
Flavivirus) was recognized as a cause of human encephalitis within the Central Valley 
during the 1930s (Howitt 1938, Howitt 1939) shortly after its discovery in Missouri 
(Muckenfuss et al. 1934) and was responsible for outbreaks as recently as 1984 in Los 
Angeles (Murray et al. 1985) and 1989 in Bakersfield (Reisen et al. 1992), California. Both 
WEEV and SLEV persisted locally within enzootic foci, with periodic introductions/
replacements by new genotypes (Kramer et al. 1997, Kramer and Fallah 1999, Reisen et al. 
2002). West Nile virus (WNV, Flaviviridae, Flavivirus) is genetically closely related to 
SLEV and was first isolated in California from a pool of Culex tarsalis Coquillett 
mosquitoes collected in Imperial Valley in July 2003 (Reisen et al. 2004). WNV rapidly 
expanded its geographic distribution to every county during the 2004 transmission season 
(Hom et al. 2005) and now is considered endemic throughout California where it is an 
annual cause of human neuroinvasive disease.
The westward progression of WNV across North America led to large outbreaks of human 
and equine neuroinvasive disease and resulted in the increased submission of mosquito 
pools to track virus outbreak risk, necessitating increased laboratory diagnostic effort and 
efficiency (Nasci et al. 2003). In response to the anticipated incursion of WNV and 
following its discovery in 2003, the number of mosquito pools tested in California by the 
Center for Vectorborne Diseases (CVEC) at the University of California, Davis, and other 
state agencies increased from 3,901 during the 2000 surveillance season to 10,297 in 2003 
(year of WNV invasion) to a peak of 35,637 during 2008; almost an order of magnitude 
increase (Fig. 1).
Initially, mosquito pools submitted to CVEC by the Mosquito and Vector Control Districts 
(MVCD) of California were tested for WEEV and SLEV by an in situ-enzyme immunoassay 
(EIA)(Chiles et al. 2004, Graham et al. 1986). This 96-well format assay detected viral 
antigen following amplification in Vero cell culture. Because SLEV requires up to 7 days to 
produce sufficient viral antigen for detection, an incubation of several days was required 
before tests could be read delaying turn-around-time. Additionally, these tests required the 
use of virus-specific antibodies and separation of WNV and SLEV was complicated by 
extensive serological cross-reactivity, necessitating additional confirmation methods (Baba 
et al. 1998). Initially, we adapted a singleplex RT-PCR using gel visualization format and 
found that these results were superior to antigen-detection tests (Vectest, RAMP and in situ 
EIA) (Chiles et al. 2004); however, this assay was not as suited for high throughput as was 
real-time amplification assays (Shi et al. 2001, Lanciotti et al. 2000). In addition, it was 
possible to multiplex real-time assays allowing the simultaneous detection of RNA from 
more than one virus or genetic portions of the same virus (Lanciotti and Kerst 2001, Zink et 
al. 2013), including closely related viruses within the same serocomplex (Barros et al. 2013). 
Given the limitations of antigen detection and electrophoresis techniques as well as the need 
for testing for multiple viruses concurrently, we developed a triplex real-time qRT-PCR for 
use by the California arbovirus surveillance program. The current paper describes the 
genetic composition and development of this multiplex assay to simultaneously detect 
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WEEV, SLEV and WNV RNA, its utility and use in California, and comparisons to virus 
isolation and antigen tests.
MATERIALS AND METHODS
Primer Selections and Design
Previously described TaqMan primer-probe sets for WNV (Lanciotti et al. 2000, Shi et al. 
2001), SLEV (Lanciotti and Kerst 2001), and WEEV (Lambert et al. 2003) initially were 
selected for evaluation. Only the NY99 strain 3526221 of WNV was used for evaluation of 
the primer/probe sets, because of the minimal genetic variation recognized in WNV in North 
America at that time (Beasley et al. 2003). SLEV and WEEV primer-probe sets were tested 
for sensitivity and specificity against representative WEEV and SLEV strains selected from 
different genetic clades described in California (Kramer and Fallah 1999, Kramer et al. 
1997). Because one strain of WEEV did not react with the Lambert et al. (2003) assay, new 
primer-probe sets were developed for WEEV with Primer Express software (Applied 
Biosystems, Inc., Foster City, CA) and were designed to recognize WEEV isolates from all 
the clades recognized from California (Kramer and Fallah 1999).
RNA Extraction
Viral RNA extraction methods followed protocols and chemistry provided by Applied 
Biosystems Inc.(ABI, Foster City, CA; now LifeTechnologies, Grand Island, NY) and 
changed over time. Initially a series of lysis buffers were compared to streamline sample 
handling and increase product yield by the ABI Prism 6700 Automated Nucleic Acid 
extraction platform. The 6700 system later was replaced with the ABI 6100 nucleic acid 
prep station system in 2007 and then by the MagMAX™ Express-96 Deep Well Magnetic 
Particle Processor (Life Technologies) in 2010.
Multiplex development
To reduce assay cost and to improve conditions for the triplex reaction, optimal primer 
concentrations were determined using the aforementioned screening primer-probe sets and 
conditions with all possible combinations of forward and reverse primer concentrations; 
50nm, 300nm to 900nm. Optimal FAM-TAMRA probe concentrations were determined 
similarly by altering its concentration from 0.05uM to 0.25μM in 50nM increments. 
Originally, the linear dynamic range of detection for reactions containing one primer-probe 
set (singleplex) and multiple primer-probe sets for multiple targets (triplex) was determined 
using real-time RT-PCRs in triplicate with 10-fold serial dilutions of a single species of 
target RNA, optimal primer and probe concentrations and thermocycler conditions of 30 min 
at 48°C for reverse transcription (RT), 10 minutes at 95° C for RT inactivation and Taq 
polymerase activation, followed by 45 cycles of 15 seconds at 95° C for denaturation and a 1 
min, 60°C annealing and extension incubations. Since 2012, we have been using the 
SensiFAST Probe Lo-ROX One-Step Kit (Bioline USA, Inc., Reno, NV) with our Life 
Technologies ViiA 7 platform that has reduced assay time to 10 min at 45°C for RT, 2 min 
at 95°C for polymerase activation, followed by 40 cycles of 5 sec at 95°C for denaturation, 
and 20 sec at 60°C for annealing and extension incubations. Ct values ≥40 were considered 
negative. Although the same primer-probe sequences were retained throughout, fluorophores 
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were modified to enhance wavelength separation. Originally, we used FAM (excitation 
wavelength = 495 nm), VIC (538 nm) and TET (521 nm) fluorophores for WNV, SLEV and 
WEEV, respectively, with our quencher conjugated to TAMRA (557 nm). Using this 
system, we occasionally would get false high Ct SLEV positives associated with samples 
with low Ct WNV positives. To correct this problem our current assay uses FAM, 
Quasar670 (647 nm) and TAMRA for WNV, SLEV and WEEV, respectively, with BHQ 
and BHQ2 non-fluorescent quenchers (Biosearch Technologies, Inc., Petaluma, CA). Ct 
values were plotted as a function of virus concentration to ensure goodness of fit and 
linearity of slope and to determine the levels of detection. Single and multiplex assays were 
compared for sensitivity for each of the three viruses.
Operational use
Mosquitoes trapped by participating vector control agencies were enumerated by sex and 
species into pools of up to 50 individual females and placed in a 5 ml mixer-mill tube 
containing two glass beads. Pools were shipped on dry ice and then, if necessary, stored at 
−80°C. Mosquito pools were thawed at room temperature, diluent containing 10% fetal 
bovine serum (FBS) and a full complement of the antibiotics (penicillin, streptomycin and 
mycostatin) added, and the mixture homogenized for three min using a Spex Centriprep 
8000D mixer-mill (SPEX SamplePrep, Metuchen, NJ). After homogenization, an aliquot of 
the mosquito slurry was removed, clarified by centrifugation, and RNA extraction and RT-
PCR performed as described above without replication. Results from RT-PCR initially were 
verified by virus isolation on Vero cell culture (obtained from the ATCC no. CCL-81) to 
ensure RNA detected in mosquitoes represented infectious virus. Results also were 
compared blindly to the Rapid Analyte Measurement Platform (RAMP, Response 
Biomedical Corp., Burnaby, BC, Canada) using field samples from the Turlock MVCD.
RESULTS
Primer Selections and Design
WEEV primer-probe set 10,248-10,314c (Lambert et al. 2003) did not detect California 
isolate BFN 3804 from the Sacramento Valley, so new primer-probe sets WEEV1 and 
WEEV2 were developed (Table 1) based on sequence analyses of California WEEV isolates 
representative of the different clades differentiated by Kramer and Fallah (1999)(Table 2). 
WEEV1 was consistently the most sensitive (i.e., had the lowest Ct score) of the three 
primer-probe sets, detected all virus strains, including BFN3804 which was not detected by 
the Lambert 10,248-10,314c set, and was selected for the multiplex assay.
Both published SLEV primers detected all representative California isolates and there were 
no significant differences (P>0.05) between Ct scores for the same viruses when tested by 
paired t-test (Table 3). The SLE-1 primer-probe set was selected for the multiplex assay.
WNV primer-probe sets WNV-ENV and WNV3111v-3239c were both capable of detecting 
the WNV isolate 3526221; however, the primer-probe set targeting the 3′ non-coding region, 
WNV-3′NC, was not, supporting previous findings (Shi et al. 2001). As such, the WNV-
ENV set (Lanciotti et al. 2000) was selected for use in the multiplex assay.
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To determine the loss of sensitivity of the primer-probe sets when combined for our 
multiplex assay, we compared Ct scores in single and multiplex assays against WNV99, 
SLEV Kern217 and WEEV Kern1703 viruses grown to 6 log10 plaque forming units (PFU)/
0.1mL in Vero cell culture, and then serially diluted 10 fold. Viral RNA was extracted using 
the MagMax system and RNA tested by RT-PCR using an ABI7900 platform (Fig. 2). Ct 
scores for all viruses were lower when the assay was run in singleplex than multiplex, and 
these differences varied among viruses, ranging from ca. 1 – 2 Ct for WNV (<1 log10 PFU) 
to 4 – 7 Ct for SLEV (1 – 1.5 log10 PFU). Because most infected Culex mosquitoes develop 
virus titers >3 log10 PFU (Reisen et al. 2005), we felt that our multiplex was sufficiently 
sensitive for operational use.
Comparison of Sensitivity and Specificity to plaque assay, in-situ EIA and RAMP
The switch from the ABI6100 manifold system to the MagMax Express system significantly 
improved WNV RNA extraction from mosquito pools as indicated by Ct scores for pools 
tested on the same ABI7900 PCR platform. When 22 pools were triturated in virus diluent 
with 10% FBS and antibiotics, the mean Ct for subsamples extracted using the ABI6100 (Ct 
= 30.3) was significantly greater (paired t = 6.85, P<0.01) than subsamples with RNA 
extracted using the MagMax express (Ct = 25.8), indicating that the MagMax Express 
improved sensitivity by more than an order of magnitude.
To verify that the RT-PCR assay was detecting infectious virus and not simply RNA, we 
attempted to isolate WNV by Vero cell culture from 60 mosquito pools collected by three 
collaborating mosquito control agencies that tested positive for WNV RNA by the multiplex 
assay. WNV was isolated from 54 of the 60 pools (90%). When compared by t-test, the 
average Ct score for the positive pools from which virus was isolated (mean Ct = 27.2, SE = 
0.45, range 19 – 34, n = 54) was significantly lower (P<0.001) than the Ct score for the 
positive pools from which virus was not isolated (mean Ct = 34.4, SE = 2.36, range 33 – 39, 
n = 6). However, we couldnot explain our inability to isolate WNV from some pools with 
the same Ct score as those where virus was isolated, but this may indicate the approximate 
limits of sensitivity of our Vero cell plaque assay or perhaps how the mosquito samples were 
handled during processing. As this was an operational evaluation, we did not attempt virus 
recovery by duplicate or sequential cell culture. In addition during 2007, 154 pools testing 
negative by qRT-PCR were retested by Vero cell plaque assay with negative results. This 
evaluation was expanded during 2008 as part of an effort to detect additional viral taxa, and 
2,041 pools submitted by 9 agencies that initially tested negative by our multiplex assay 
were retested by Vero cell plaque assay on 6 well plates, of which 21 (1%) yielded plaques; 
typically <5 per well indicating low viral titer. Of these plaque-positive cultures, 20 tested 
positive for WNV when retested by singleplex RT-PCR; one isolate from Cx. tarsalis 
collected in the Coachella Valley was not detected by our WNV RT-PCR. The following 
year, 1,147 multiplex negative pools from two of the same agencies again were tested by 
Vero cell plaque assay with negative results. Overall, our WNV RT-PCR processing 
produced 0.6% false negatives during this three-year period (i.e., pools reported as negative 
by RT-PCR, but positive by plaque assay); WEEV or SLEV was not detected by either 
method. One possible contributing factor to these false negatives was the detection of a 
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mutation within the envelope gene in the probe-binding region of WNV that lowered 
sensitivity of our assay by an order of magnitude (Brault et al. 2012).
During 2003, 356 mosquito pools from 2 agencies were tested by both the in-situ EIA and 
qRT-PCR assays (RNA extracted by ABI6700, RT-PCR by ABI7900). Overall, 32 pools 
tested positive and 317 tested negative by both assays (98% agreement); 5 pools were 
positive by qRT-PCR but were negative by EIA, whereas 2 positive by EIA were negative 
by qRT-PCR. Based on the previous isolation attempts, we feel that these 5 negatives by the 
EIA were related to lower Vero cell plaque assay sensitivity, whereas the two positive by 
EIA may have again contained the mutation discussed above.
During 2006, 1,042 pools collected by the Turlock MVCD were ground in mosquito diluent 
and aliquots tested by RAMP test at the Turlock MVCD and then sent to CVEC for 
confirmation by qRT-PCR (RNA extraction by ABI6100, RT-PCR by ABI7900). Similar to 
the in situ-EIA which also tested for antigen, there were 26 positive and 996 pools negative 
by both tests (98% agreement) as well as 16 negative by RAMP but positive by RT-PCR 
and 4 positive by RAMP but negative by RT-PCR. Again, we felt the 16 pools determined 
to be negative by RAMP but positive by qRT-PCR reflected the lower RAMP sensitivity; 
cut-off at ca. 3–4 log10 PFU/mL based on repeated tests on WNV dilution series by multiple 
agencies. Most of these RAMP negative pools were detected early in the season when 
temperatures are cooler and virus replication rates within Culex were slower (Reisen et al. 
2006). We could not explain the four RAMP positives negative by RT-PCR, but these 
samples had RAMP scores between 52 and 168 and false positives with similar intermittent 
scores were reported previously (Kesavaraju et al. 2012).
Mosquito surveillance
In 2003 following the detection of WNV in California, an unprecedented number of 
agencies submitted mosquito pools to CVEC. Overall, 39 different agencies submitted 
10,297 pools from 25 different mosquito species. A total of 37 mosquito pools were positive 
by the in situ-EIA for at least one arbovirus: 32 WNV, 4 SLEV and 1 WEEV. One mosquito 
pool was identified by the in situ-EIA to have contained both WNV and SLEV.
From 2004 through 2013, 271,889 mosquito pools were tested by qRT-PCR, of which 
15,629 were positive for WNV, 55 were positive for WEEV, and none were positive for 
SLEV (Fig. 1). In 2005 our multiplex assay identified two pools of Cx. tarsalis positive for 
both WEEV and WNV RNA. From 817 to 2,866 pools tested positive for WNV each year. 
Of these total pools, 186,576 (69%) were tested by multiplex at CVEC. In 2004, all pools 
were tested by CVEC, however, over time some MVCDs constructed their own laboratories 
and began testing for WNV by singleplex or multiplex RT-PCR, until by 2013, 47% of the 
30,144 of the total state pools were tested by other agencies. Currently, all mosquito control 
agencies use the same primer-probe sets, extract RNA by MagMax express, detect virus 
using the ABI7500 platform, and annually pass a blinded proficiency panel administered by 
CVEC. Agencies that initially failed the proficiency panel were provided training and then 
were retested until their assay results were considered sufficiently sensitive and produced a 
linear dose-response curve similar to results in Fig. 3, the 2013 RT-PCR proficiency panel 
results for 9 agencies and CVEC.
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During 2006, we estimated the time required to test each of 12,706 pools after they were 
received at our laboratory (Fig. 4). Overall, 8,958 pools (65%) were processed and reported 
back to the submitting agency within 48 hours. In our testing paradigm at that time, negative 
pools (Ct score >40) were reported immediately, whereas pools positive for WNV by the 
ENV gene primer-probe set were confirmed by a second assay using primer-probe from the 
NS1 region. If the 1st and 2nd tests did not agree, then the sample was held until the 
following week, RNA was re-extracted and re-tested with the ENV primer-probe set. 
Samples positive by the second assay run were reported as positive. Those negative by the 
2nd assay and after re-extraction and retesting were considered to be negative. Since this 
time, we have expedited turn-around-time by attempting confirmation only for pools with Ct 
values >30; those with values <30 are now immediately classified as positive based almost 
100% confirmation and our ability to isolate infectious virus from these pools. Although 
variable among years, during 2012, for example, there were 3,002 WNV RT-PCR positive 
pools, of which 788 (26%) had Ct scores >30 and were confirmed by the paradigm 
described above; most confirmed by retesting with the NS1 primer-probe.
DISCUSSION
In response to expanded mosquito surveillance to estimate human infection risk and direct 
intervention, we developed a multiplex TaqMan qRT-PCR-based assay that detected RNA 
from WEEV, SLEV and WNV strains known to circulate in California. In combination with 
efficient data management through the Surveillance Gateway net-based reporting system 
(Park et al. 2008, Lozano-Fuentes et al. 2011), we were able to provide efficient, near real-
time risk estimates. If mosquito traps were set on Monday, specimens identified and shipped 
on Tuesday, and received by our laboratory by Wednesday, results were available to 
submitting agencies by sometimes by Wednesday afternoon, but usually by Thursday or 
Friday at the latest, and within time to coordinate intervention efforts based on the California 
Mosquito-borne Virus Surveillance and Response Plan (Kramer 2014). In general, our WNV 
RT-PCR results for mosquito pools have preceded or accompanied increases in the risk of 
human infection estimated by the Response Plan and the occurrence of human cases (Reisen 
et al. 2009, Kwan et al. 2010, Reisen et al. 2008).
West Nile virus has demonstrated very low genetic variability since its introduction into 
North America in 1999 (Beasley et al. 2003, Lanciotti et al. 2002). The primer/probe set 
designed against the envelope gene of a WNV isolate from 1999 (Lanciotti et al. 2000) 
demonstrated a sensitivity level of 0.1 PFU per mosquito pool and was designated as the 
screening primer for WNV. A primer/probe combination from the NS1 gene region was 
demonstrated to have a sensitivity of 1.0 PFU and was used for confirmation of positives by 
the envelope set (Lanciotti et al. 2000). Unlike WNV, multiple genotypes of SLEV have 
been identified to circulate in California since the 1950s (Kramer et al. 1997, Reisen et al. 
2002). The SLEV TaqMan assay had a detection level of less than a single PFU for all of the 
recently circulating SLEV genotypes; however, reduced sensitivity was identified for viral 
genotypes that differed from the prototype strain from which the primers were designed. 
New primer and probes were designed for WEEV, because the previously published 
reagents were unable to identify all strains known to have circulated in California. 
Alignments of fifty-five partial sequences from the E2 envelope glycoprotein of Californian 
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WEEV isolates were performed and two primer/probe sets were identified that detected 
WEEV at a sensitivity level of 0.01 PFU.
The sensitivity of our multiplex assay was greater than standard virus isolation by Vero cell 
culture and antigen detection assays. Improvements in RNA extraction and use of the One-
Step Fastkit using the Vii7a RT-PCR platform has further enhanced original sensitivity as 
well as shortened processing time. Multiplexing of the reagents for the concurrent testing for 
three viral RNA species in the same reaction was associated with some reduced sensitivity, 
but did not affect specificity of the assay with new fluorophores having distinct wavelength 
activation.
The use of molecular approaches such as the assays described herein for the detection of 
viral RNA has the potential disadvantage of not detecting subtle genetic change due to the 
high level of specificity afforded by specific primer/probe sets. This fact was exemplified by 
the finding of reduced sensitivity of our SLEV probe for the different strains of SLEV that 
have circulated in California over the past fifty years. Similarly a spontaneous WNV 
mutation within the probe sequence reduced assay sensitivity by an order of magnitude 
(Brault et al. 2012). Changes to the sequence of the primer and probe binding regions from 
these viruses indicated that only one nucleotide difference within the probe region can affect 
the sensitivity of the assay and that only a small number of mutations can be tolerated in the 
primers for the maintenance of sensitivity. The minimal effects on relative sensitivity due to 
multiplexing could easily allow future assays to target multiple gene regions for individual 
viruses to reduce the negative impact of similar subtle genetic variation on assay sensitivity.
Although excellent for decision support to direct intervention against a specific suite of 
viruses that utilize the same vectors, reliance of highly specific and high throughput assays 
precludes the ability to detect the emergence of local or introduction of novel viruses, for 
which the assays were not intended. Our future research and development efforts will target 
the use of new sequencing tools to provide a balanced approach to track a variety of viruses; 
however, these methods currently are cost prohibitive to provide the necessary spatial and 
temporal resolution to direct intervention strategies. Future surveillance paradigms may 
employ an eclectic approach of modified multiplexable platforms that can serve this 
traditional role for arboviral surveillance in concert with deep sequencing analyses for the 
detection of novel genetic variants with potentially altered vector infection and/or virulence 
phenotypes.
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Figure 1. 
Mosquito pools tested in California from 2000 – 2013. Shown are the annual number of 
pools tested and the number positive for western equine encephalitis (WEEV), St. Louis 
encephalitis (SLEV) and West Nile (WNV) viruses each year. Arrow shows the start of 
testing using only qRT-PCR.
Brault et al. Page 11
J Med Entomol. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. 
Sensitivity of the primer-probe sets run in duplicate as single or multiplex. Plotted are mean 
qRT-PCR Ct scores as a function of virus titer assayed by Vero cell plaque titration as log10 
plaque forming units (PFU) per 0.1mL. RNA extraction by MagMax, RT-PCR by ABI7900.
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Figure 3. 
Results of blind proficiency panel testing for WNV RNA by 9 local agencies and CVEC 
(fitted line) in 2013. Shown are the RT-PCR Ct score plotted as a function of WNV titer 
estimated by plaque assay on Vero cell culture. Note variation in sensitivity. At CVEC RNA 
was extracted by MagMax Express and RT-PCR run using 1-step fast kit on an ABI Vii7a 
platform.
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Figure 4. 
Average processing time in days for mosquito pools after receipt at CVEC during 2006.
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Table 1
Genetic sequences of the WEEV primer-probe sets used in the evaluations described in Table 2.
Primer/probe set Genomic orientation Primer sequences
WEEV-1 forward 5′-GTCTTCAACTCGCCGGATCTTA -3′
Forward (probe) 5′-FAM-CACACAGACCACTCAGTGCAAGGTAAACTGC-TAMRA-3′
reverse 5′-GGTGTCAAGCGGAATGGAA-3′
WEEV-2 forward 5′-AGGTAAACTGCACATTCCATTCC-3′
Forward (probe) 5′-FAM-CCGACAGTCTGCCCGGTTCCG-TAMRA-3′
reverse 5′-TTCGTGACTGTAGGCGTGTGA-3′
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Table 2
Ct values for 15 California strains of WEEV tested using 3 primer-probe sets. Shown are virus titers in log10 
PFU/0.1 ml. Extraction performed by ABI 6700, RT-PCR on ABI 7900.
Strain Titer LAMB WEEV1 WEEV2
CNTR 3.2 18.31 17.23 18.33
BFN3060 3.6 19.58 18.75 19.91
Lake 43 4.6 12.39 10.77 11.76
S81-22 3.3 24.95 23.60 24.63
Sac 74 3.0 18.29 16.51 17.73
A7712 4.3 17.08 15.89 17.26
CHLV 33 2.8 23.63 17.26 18.77
E14416 5.4 16.00 15.17 16.28
CHLV 592 4.6 15.90 15.44 16.75
Bc28cl5 2.8 17.35 16.12 18.76
CHLV 129 3.0 18.15 17.18 18.60
Fleming 5.3 14.71 13.96 14.86
COAV 746 3.3 18.61 17.34 18.94
BFS 1703 6.8 16.25 15.10 16.41
BFN 3804 4.6 >40.00 13.29 15.23
Mean 17.94 16.24 17.61
SE 3.14 2.73 2.73
LAMB sequences = 10,248-10,314c (Lambert et al. 2003)
WEEV1 and WEEV2 sequences in Table 1.
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Table 3
Ct values for two published primer-probe sets against 6-strains of SLEV from California. Titer is log10 
PFU/0.1 mL estimated by Vero cell plaque assay. Extraction by ABI 6700, RT-PCR on ABI 7900 platform
Strain Titer SLE1 SLE2
COAV 353 6.3 18.54 18.14
COAV 750 5.3 27.95 30.09
COAV 608 4.4 13.51 18.78
COAV 477 5.9 17.63 16.34
KERN 217 4.6 18.75 26.61
KERN 1750 4.0 26.72 34.00
Mean 20.50 24.00
SE 2.30 2.97
SLE1 = 2420/2487c/2444
SLE2 = 834/905c/857
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